Imperial Chemical Industries (ICI) was a British chemical company and was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of leading British chemical companies in 1926. Its headquarters were at Millbank in London, and it was a constituent of the FT 30 and later the FTSE 100 indices.

The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested. These could be "reduced to a powder under the thumb", a strong marketing argument at the time.

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.

Beth Israel Hospital is an American private company located in Boston, MA. The firm provides healthcare services.

R.P. Scherer GmbH & Co. KG, part of Catalent, Inc., is a company headquartered in Eberbach, Germany, that develops, manufactures and sells pharmaceutical products.

Ciba-Corporate Insurance Brokers Association A/S operates as specialized insurance brokers. It offers insurance solutions and daily administration for companies both nationally and internationally. The firm provides analysis of risks, including adaptation; solution proposals and market research; online access to policies and meetings; risk report; and treatment of injuries. The company was founded on June 19, 2014 and is headquartered in Ballerup, Denmark.

Markets and distributes specialty, artisanal and farmstead cheese products

Boehringer Ingelheim Corporate Center GmbH, part of C.H. Boehringer Sohn AG & Co. KG, is a company headquartered in Ingelheim am Rhein, Germany. The firm leases real estate properties. It was founded in 2016.

Gruppo Lepetit SRL, part of Sanofi, is a company headquartered in Italy. The firm manufactures pharmaceuticals and proprietary medicines, medical and surgical supplies.

MedDEV, Inc. is a privately held company incorporated in the state of Washington in 2006

Delalande SA, part of Sanofi, is a French company. The firm provides construction services.

Rohm and Haas Company is a manufacturer of speciality chemicals for end use markets such as building and construction, electronic devices, packaging, household and personal care products. Headquartered in Philadelphia, the company is organised into three business groups of Specialty Materials, Performance Materials and Electronic Materials, and also has two stand-alone businesses of Powder Coatings and Salt. Formerly a Fortune 500 Company, Rohm and Haas employs more than 17,000 people in 27 countries, with its last sales revenue reported as an independent company at US$8.9 billion. Dow Chemical Company bought Rohm and Haas for $15 billion in 2009.

Rentokil Ltd., part of Rentokil Initial Plc, is a British company located in Camberley. The firm provides pest control services.

Nippon Chemiphar Co., Ltd. engages in the healthcare business. It manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents. It operates through the Pharmaceuticals and Others segments. The Pharmaceuticals segment manufactures and sells prescription drugs. The Others segment includes safety testing consignment, healthcare, and real estate businesses. The company was founded by Akira Yamaguchi on June 16, 1950 and is headquartered in Tokyo, Japan.

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Zhengzhou Taifeng Pharmaceutical Co., Ltd., established on 1998-06-28, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export;Drug Wholesale;Drug retail;Drug internet information service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Medical Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;sales agent;Conference and Exhibition Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)